Revenue

Ziff Davis nets a massive windfall by selling its Connectivity division, including Ookla and Speedtest, to Accenture in a deal reshaping network intelligence.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

Three investment heavyweights—BCI, Norges Bank, and Brookfield—have formed Northview Energy, a new firm set to scale de-risked renewable assets.

With over 100% revenue growth, Ada's success highlights a major industry shift from AI experiments to fully integrated agentic customer experience models.

New research reveals a media blind spot for hearing loss, fueling stigma. A new campaign aims to change the picture and normalize hearing aids for millions.

Modaxo's new brand, Aerivo, emerges from an ADB SAFEGATE acquisition, poised to enhance airport efficiency with its cloud-native Flightivity suite.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

Esperion's $75M+ deal for Corstasis and its novel nasal diuretic, Enbumyst, targets a $4B market and a new era of at-home edema management.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

A new partnership aims to solve the AI industry's energy crisis, bringing high-efficiency liquid cooling to thousands of data centers.

The soundtracking giant's new desktop app lets creators drag and drop music directly to their timeline, cutting production time and boosting flow.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A new report reveals Canadians are overwhelmed by scams, making them vulnerable to AI-driven fraud. Is a national strategy enough to fight back?

Giacomo Billi reclaims full ownership of Alive Capital, launching an ambitious plan to scale renewables and storage across Southeast Europe's booming market.

Swiss sportswear giant On reports a landmark 2025 with record sales and ambitious goals, yet a currency hit complicates the bottom-line profit story.

A new partnership combines intelligent routing and a NaaS platform to solve AI's biggest network challenges, targeting the booming Asia-Pacific market.

Proofpoint launches its AI-powered Nuclei Suite, offering enterprise-grade compliance tools to resource-strapped small and medium businesses.

A €21.5M consortium is launching clinical trials for AI that assists in brain and cancer surgery, aiming to ease a critical European doctor shortage.

A major renewal with a 30M-client bank highlights the industry's shift to biometrics, boosting BIO-key's finances and solidifying its market niche.